As part of your daily routine as an active trader or investor, it's important to track the stocks in the market that are making the biggest percentage gains and the biggest percentage losses.

Stocks that are making large moves to the upside are favorites among short-term traders who want to capture some of that massive volatility. Stocks that are making big-percentage moves are usually in play because their sector is becoming attractive or they have a major fundamental catalyst such as a recent earnings release. Sometimes stocks making big moves have been hit with an analyst upgrade or an analyst downgrade.

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits. If you time your trade correctly, combining with fundamental trends, discipline and sound money management, you will be well on your way to investment success.

With that in mind, let's take a closer look at a several stocks under $10 that are making large moves to the upside.

Sphere 3D

Sphere 3D  (ANY)  provides virtualization technology and data management solutions in the Americas, Europe, the Middle East, Africa and the Asia Pacific. This stock traded up 1.3% to $1.51 in Friday's trading session.

  • Friday's Range: $1.41-$1.56
  • 52-Week Range: $1.02-$7.49
  • Friday's Volume: 208,000
  • Three-Month Average Volume: 294,834

From a technical perspective, Sphere 3D trended notably higher on Friday and displayed some relative strength versus the overall market weakness with decent upside volume flows. This trend to the upside has now started to push shares of Sphere 3D back above its 50-day moving average of $1.45 a share, and it's quickly moving the stock within range of triggering a near-term breakout trade. That trade will trigger if this stock manages to take out some near-term overhead resistance levels at $1.56 to $1.60 a share with high volume.

Traders should now look for long-biased trades in Sphere 3D as long as it's trending above its 50-day moving average of $1.45 a share or above its 20-day moving average of $1.32 a share and then once it sustains a move or close above those breakout levels with volume that hits near or above 294,834 shares. If that breakout hits soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $1.84 to $1.94, or even $2 to $2.25 a share.

Celator Pharmaceuticals

Celator Pharmaceuticals  (CPXX) , a clinical stage biopharmaceutical company, develops therapies to treat cancer. This stock traded up 3.2% to $1.41 in Friday's trading session.

  • Friday's Range: $1.37-$1.41
  • 52-Week Range: $1.12-$3.26
  • Friday's Volume: 156,000
  • Three-Month Average Volume: 205,948

From a technical perspective, Celator Pharmaceuticals spiked notably higher on Friday and displayed some relative strength versus the overall market weakness with decent upside volume flows. This bump to the upside has now started to push this stock back above its 20-day moving average of $1.37 a share, and it's quickly moving shares of Celator Pharmaceuticals within range of triggering a near-term breakout trade. That trade will trigger if this stock manages to clear some near-term overhead resistance levels at $1.42 to $1.44 a share with high volume.

Traders should now look for long-biased trades in Celator Pharmaceuticals as long as it's trending above some near-terms support levels at $1.30 or $1.25 a share and then once it sustains a move or close above those breakout levels with volume that hits near or above 205,948 shares. If that breakout takes hold soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at its 50-day moving average of $1.56 to $1.59, or even $1.70 to $1.85 a share.

Performance Sports Group

Performance Sports Group  (PSG) , together with its subsidiaries, designs, manufactures and distributes performance sports equipment, related apparel and accessories for ice hockey, roller hockey, lacrosse, baseball and softball, primarily in the U.S., Canada, and Europe. This stock traded up 3.7% to $7.70 in Friday's trading session.

  • Friday's Range: $7.21-$7.73
  • 52-Week Range: $5.37-$21.72
  • Friday's Volume: 409,000
  • Three-Month Average Volume: 431,547

From a technical perspective, Performance Sports Group trended notably higher on Friday right above its 20-day moving average of $7.06 a share with decent upside volume flows. This spike to the upside has now pushed shares of Performance Sports Group into breakout territory, since the stock closed above some near-term overhead resistance at $7.53 a share. This stock is now quickly trending within range of triggering another key breakout trade. That trade will trigger if shares of Performance Sports Group manages to take out Friday's intraday high of $7.73 a share and then once it clears more key resistance at around $8 a share with high volume.

Traders should now look for long-biased trades in Performance Sports Group as long as it's trending above its 20-day moving average of $7.06 a share or above more near-term support around $6.50 a share and then once it sustains a move or close above those breakout levels with volume that hits near or above 431,547 shares. If that breakout fires off soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at its 50-day moving average of $9.06 or $9.50 a share.

PharmAthene

PharmAthene  (PIP) , biodefense company, develops and commercializes medical counter measures against biological and chemical threats in the U.S. This stock traded up 6.1% to $1.73 in Friday's trading session.

  • Friday's Range: $1.60-$1.74
  • 52-Week Range: $1.20-$2.09
  • Friday's Volume: 2.91 million
  • Three-Month Average Volume: 106,592

From a technical perspective, PharmAthene ripped sharply higher on Friday back above its 200-day moving average of $1.64 a share and over its 50-day moving average of $1.67 a share with monster upside volume flows. This high-volume spike to the upside is now quickly pushing shares of PharmAthene within range of triggering a big breakout trade above some key overhead resistance levels. That trade will hit if this stock manages to take out some near-term overhead resistance levels at $1.74 to $1.75 a share with high volume.

Traders should now look for long-biased trades in PharmAthene as long as it's trending above some key near-term support levels at $1.60 or $1.54 a share and then once it sustains a move or close above those breakout levels with volume that registers near or above 106,592 shares. If that breakout develops soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $1.90 to its 52-week high of $2.09 a share.

Caladrius Biosciences

Caladrius Biosciences  (CLBS) , a clinical-stage biopharmaceutical company, develops cell based therapeutics in the U.S. This stock traded up 3.9% to 55 cents per share in Friday's trading session.

  • Friday's Range: $0.52-$0.56
  • 52-Week Range: $0.40-$4.26
  • Friday's Volume: 181,000
  • Three-Month Average Volume: 349,031

From a technical perspective, Caladrius Biosciences spiked notably higher on Friday right above some near-term support at 49 cents per share with lighter-than-average volume. This display of relative strength versus the overall market weakness for shares of Caladrius Biosciences is now quickly pushing this name within range of triggering a major breakout trade. That trade will trigger if this stock manages to take out its 20-day moving average of 57 cents per share and then above more key resistance levels at 60 cents to around 62 cents per share with high volume.

Traders should now look for long-biased trades in Caladrius Biosciences as long as it's trending above some key near-term support levels at 50 cets or 49 cents per share and then once it sustains a move or close above those breakout levels with volume that registers near or above 349,031 shares. If that breakout kicks off soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at 66 to 70 cents per share. Any high-volume move above 70 cents per share will then give this stock a chance to re-fill some of its previous gap-down-day zone from January that started just above 90 cents per share.

Boot Barn

Boot Barn  (BOOT) , a lifestyle retail company, operates specialty retail stores in the U.S. This stock traded up 5.1% to $8.33 in Friday's trading session.

  • Friday's Range: $7.92-$8.50
  • 52-Week Range: $5.20-$34.43
  • Friday's Volume: 1.26 million
  • Three-Month Average Volume: 748,616

From a technical perspective, Boot Barn ripped sharply higher on Friday and counter-trended versus the overall market weakness with strong upside volume flows. This stock has been uptrending strong over the last few weeks, with shares soaring higher off its new 52-week low of $5.20 a share to its recent high of $8.57 a share. During that uptrend, shares of Boot Barn have been consistently making higher lows and higher highs, which is bullish technical price action. This high-volume trend to the upside is now quickly pushing this stock within range of triggering a near-term breakout trade. That trade will hit if shares of Boot Barn manage to take out Friday's intraday high of $8.50 a share and then over more resistance at $8.57 a share with high volume.

Traders should now look for long-biased trades in Boot Barn as long as it's trending above Friday's intraday low of $7.92 a share or above its 20-day moving average of $7.24 a share and then once it sustains a move or close above those breakout levels with volume that hits near or above 748,616 shares. If that breakout develops soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at its 50-day moving average of $10.04 to possibly $11 a share.

Intrawest Resorts

Intrawest Resorts  (SNOW)  operates as a mountain resort, adventure and real estate company in North America. This stock traded up 2.1% to $8.46 in Friday's trading session.

  • Friday's Range: $8.22-$8.50
  • 52-Week Range: $6.95-$12.75
  • Friday's Volume: 641,000
  • Three-Month Average Volume: 240,292

From a technical perspective, Intrawest Resorts trended notably higher on Friday and displayed relative strength versus the overall market weakness right off its 20-day moving average of $8.29 a share and back above its 50-day moving average of $8.37 a share with strong upside volume flows. This high-volume spike to the upside is now quickly pushing shares of Intrawest Resorts within range of triggering a big breakout trade above some key overhead resistance levels. That trade will trigger if this stock manages to take out some near-term overhead resistance levels at $8.66 to around $8.75 a share with high volume.

Traders should now look for long-biased trades in Intrawest Resorts as long as it's trending above some key near-term support at $8.09 a share and then once it sustains a move or close above those breakout levels with volume that hits near or above 240,292 shares. If that breakout gets started soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $9.37 to $9.50, or even its 200-day moving average of $9.70 to $10 a share.

Argos Therapeutics

Argos Therapeutics  (ARGS) , a biopharmaceutical company, focuses on the development and commercialization of personalized immunotherapies for the treatment of cancer and infectious diseases in North America. This stock traded up 2.9% to $3.14 in Friday's trading session.

  • Friday's Range: $3.00-$3.15
  • 52-Week Range: $1.61-$9.64
  • Friday's Volume: 90,000
  • Three-Month Average Volume: 106,258

From a technical perspective, Argos Therapeutics trended notably higher on Friday and counter-trended versus the overall market weakness with decent upside volume flows. This stock has been uptrending strong over the last month, with shares moving higher off its low of $1.83 to its recent high of $4 a share. During that uptrend, shares of Argos Therapeutics have been making mostly higher lows and higher highs, which is bullish technical price action. This strength to the upside on Friday is now quickly pushing this stock within range of triggering a near-term breakout trade above some key overhead resistance levels. That trade will trigger if this stock manages to take out some near-term overhead resistance levels at $3.20 to around $3.40 a share with high volume.

Traders should now look for long-biased trades in Argos Therapeutics as long as it's trending above some key near-term support levels at $2.75 or $2.55 a share and then once it sustains a move or close above those breakout levels with volume that registers near or above 106,258 shares. If that breakout develops soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $4 to $4.20, or even $4.55 to $5 a share.

Disclosure: This article is commentary by an independent contributor. At the time of publication, the author held no positions in the stocks mentioned.

More from Opinion

Flashback Friday: Johnson & Johnson Hits Take Historic Plunge

Flashback Friday: Johnson & Johnson Hits Take Historic Plunge

Adobe's Decline After Earnings Reflects a More Risk-Averse Market

Adobe's Decline After Earnings Reflects a More Risk-Averse Market

Throwback Thursday: GE, GM Head in Opposite Directions

Throwback Thursday: GE, GM Head in Opposite Directions

Tech Reviews Aren't Always a Good Predictor of Demand (See: Apple's iPhone XR)

Tech Reviews Aren't Always a Good Predictor of Demand (See: Apple's iPhone XR)

Wednesday Wrap-Up: Roku Rebounds, Tesla Ships

Wednesday Wrap-Up: Roku Rebounds, Tesla Ships